Areas of Focus
- Lung Cancer
- Tumor Antigen-Specific T Cell Immune Response
- Tumor Microenvironment Interactions
- T Cell Response in Tumor and Autoimmune Diseases
Publications
- Siglec-9 acts as an immune checkpoint molecule on macrophages in glioblastoma, restricting T cell priming and immunotherapy response., Mei Y, Wang XM, Zhang J, Liu D, He JJ, Huang CL, Liao J, Wang YZ, Feng YY, Li HY, Liu XY, Chen LD, Yi W, Chen X, Bai HM, Liang ZG, Qiu L, Hui Y, Zhang QL, Leng Q, Chen J, Jia GS, 2023
- Single-Cell Analyses Reveal Mechanisms of Cancer Stem Cell Maintenance and Epithelial-Mesenchymal Transition in Recurrent Bladder Cancer., Wang H, Mei Y, Luo C, Huang Q, Wang Z, Lu GM, Qin L, Sun Z, Huang CW, Yang ZW, Chen J, Yin W, Qian CN, Zeng J, Chen L, Leng Q, Guo Y, Jia G, 2021
- Pre-existing heterologous T-cell immunity and neoantigen immunogenicity., Leng Q, Tarbe M, Long Q, Wang F, 2020
- NCoR1 restrains thymic negative selection by repressing Bim expression to spare thymocytes undergoing positive selection., Wang J, He N, Zhang N, Quan D, Zhang S, Zhang C, Yu RT, Atkins AR, Zhu R, Yang C, Cui Y, Liddle C, Downes M, Xiao H, Zheng Y, Auwerx J, Evans RM, Leng Q, 2017
- TLR3 signaling in macrophages is indispensable for the protective immunity of invariant natural killer T cells against enterovirus 71 infection., Zhu K, Yang J, Luo K, Zhang N, Yang CH, Chen J, Xu B, Guo NN, Wang J, Cui Y, Wang Y, Deng C, Qin C, Ge B, Hao S, Yang CF, Leng Q, 2015
Awards
- 2009: Specially Appointed Professor of the 'Hundred Talents Program' of the Chinese Academy of Sciences
- 2010: Excellent Youth Award of the Shanghai Institute of Life Sciences, Chinese Academy of Sciences-Sinofi Aventis
- 2015: Zhu Li Yuehua Excellent Teacher Award of the Chinese Academy of Sciences